Latest Blogs

Nov 21, 2019
Dr. Clarissa Mathias, chair-elect of ASCO's International Affairs Committee, speaks to the incredible impact that ASCO volunteers have on cancer care around the world.
Nov 19, 2019
Dr. Aditya Bardia and I discuss the deep and sincere bonds we form not just with our patients but with their families. How can we ensure their needs are met, especially after a patient dies?
Nov 14, 2019
If you have a passion and a calling, writes Ms. Bincy Mathew, don't let the fear of what others might think keep you from achieving your goals.
Nov 13, 2019
He was lonely and afraid after a diagnosis of prostate cancer, and I hope, wherever he is, that he is doing well.
Subscribe to this column

L. Michael Glode, MD, FACP, FASCO

L. Michael Glodé, MD, FACP, FASCO, is a Professor Emeritus at the University of Colorado Cancer Center. He previously served as Chair of ASCO's Integrated Media and Technology and Cancer Education Committees. He is the author of prost8blog, a blog to help patients and their families understand various aspects of prostate cancer.

May 30, 2015
I think I may have absorbed more information in this format than the usual scurrying about in Chicago, and my own bed was terrific.
May 26, 2015
This year, I plan to follow the ASCO Annual Meeting from the comfort of my home. It will be the first year of “missing” the Annual Meeting, and one question is whether I will have the discipline to watch enough presentations to feel like I have been sufficiently updated.
Apr 30, 2015
For the past month or so, one patient after another has come in with the question, “So, what do you think about 4-MU?” or “Did you hear about poliovirus killing cancer?” Actually, I have heard next to nothing about either, but of course I was intrigued as to where my patients get their information.
Apr 07, 2015
It has long been held that testosterone is the root of all evil—probably true for most wars, and possibly true for the development of prostate cancer....
Mar 05, 2015
I recently attended the co-sponsored Genitourinary Cancers Symposium. As usual, it was somewhat of a “firehose to take a drink” scenario with great presentations, more posters than you could possibly absorb, and lots of progress on many fronts.
Feb 03, 2015
In the past decade, a number of labs and companies have developed techniques to further define how a patient with prostate cancer, or suspected cancer, is likely to do. There are at least a dozen tests that are in various stages of commercialization, and it would be difficult to do justice to all...

Pages